Treatment with imatinib decreased expansion of CML iCD34+CD38− cells to the level observed in normal BM iCD34+CD38− cultures (Fig. 2a). The gene discussed is CD38; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.